India Inc Calls For Regulatory Easing; Looks To Biosimilar Launches Including Keytruda

 
• By Vibha Ravi
IPA 2024 Summit Patient Needs Panel
Left To Right - Ratnesh Jain, MD, Mumbai Biocluster; Ravi Shankara, Sr GM, Sun Pharma; Dhananjay Patankar, former VP, Syngene; Sanjeev Gupta, Sr VP Ipca Labs • Source: Scrip/Citeline

More from Business

More from Scrip